Selumetinib (Koselugo)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Selumetinib (Koselugo), covering 2015-06-30 to 2025-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors [Phase 2]